发明名称 |
Methods for the modulation of Leishmania major infection in mammals |
摘要 |
Embodiments of the invention include methods for treating an infection of a mammal by an organism, such as Leishmania major by administering an effective amount of an inhibitor of indolamine 2,3-dexygenase (IDO). A preferred inhibitor is 1-methyl-tryptophan (1MT). The treatment can be highly beneficial as a treatment for visceral leishmaniasis.
|
申请公布号 |
US2010261774(A1) |
申请公布日期 |
2010.10.14 |
申请号 |
US20100658895 |
申请日期 |
2010.02.16 |
申请人 |
CHILDREN'S HOSPITAL MEDICAL CENTER |
发明人 |
KARP CHRISTOPHER L.;DIVANOVIC SENAD |
分类号 |
A61K31/405;A61P33/02 |
主分类号 |
A61K31/405 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|